Global Spine Biologics Market 2018-2022
About Spine Biologics
The spine biologics market is fragmented due to the presence of several players. The market is quite competitive and to sustain the competition, the vendors are focusing on differentiating their products based on price, quality, regulatory compliance, and innovation. Based on product type the market can be segmented as Bone grafts, BMPs, and BMAC. During 2017, the bone grafts segment accounted for the major share of the spine biologics market. Allograft is the method by which tissue transplant takes place between individuals with a different genotype. It is extensively used in several life-saving procedures such as pain relief, limbs repair, and improvement of the life quality of patients.
Technavio’s analysts forecast the global spine biologics market to grow at a CAGR of 4.09% during the period 2018-2022.
Covered in this report
The report covers the present scenario and the growth prospects of the global spine biologics market for 2018-2022. To calculate the market size, the report considers the revenue generated from the sales of spine biologics.
The market is divided into the following segments based on geography:
Technavio Announces the Publication of its Research Report – Global Spine Biologics Market 2018-2022
Technavio recognizes the following companies as the key players in the global spine biologics market: Alphatec Spine, Globus Medical, Medtronic, and NuVasive.
Other Prominent Vendors in the market are: AlloSource, AMENDIA, ChoiceSpine, DePuy Synthes, Exactech, and Harvest Technologies.
Commenting on the report, an analyst from Technavio’s team said: “The latest trend gaining momentum in the market is increasing adoption of minimally invasive surgeries. Surgeons are opting for minimally invasive surgeries rather than open surgery owing to the various benefits including less injury to tissue, less pain, and high accuracy. Minimally invasive (MI) surgeries allow surgeons to operate through small incisions and they are mainky adopted for the treatment of several spinal disorders such as back and neck pain. The growing adoption of MI spinal surgeries will subsequently drive the growth of this global market.”
According to the report, one of the major drivers for this market is growing geriatric population. It has been observed that there will be a significant increase in the aging population over the next few years. The increase in geriatric population results in a rise in number of individuals with spine deformities and defects. To overcome these challenges, surgeons use advanced spine biologics mechanisms such as extreme lateral interbody fusion and direct lateral interbody fusion. Advancements in spine biologics make it quite easy for surgeons to treat people suffering from pre- and post-operative complications due to hypertension, diabetes, and obesity.
Alphatec Spine, Globus Medical, Medtronic, NuVasive, AlloSource, AMENDIA, ChoiceSpine, DePuy Synthes, Exactech, and Harvest Technologies.
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.Download eBook